ExpreS2ion Biotech Holding AB announces that it has appointed Mr. Keith Alexander as new Chief Financial Officer (CFO). Mr. Alexander brings more than 20 years of corporate banking and strategy consulting experience and will initially be focused on strengthening the Company's financial strategies and investor relations function. Mr. Alexander will begin his employment on October 1, 2020 and be based out of ExpreS2ion's headquarters in Hørsholm, Denmark. The appointment of Mr. Alexander follows the strategy transformation announced earlier this year. Mr. Alexander (44) joins with over 20 years of experience in investment markets, investor communications, corporate strategy and business development. He joins from Danske Bank Asset Management, where he was responsible for the Fixed Income & Credit Advisory & Product Specialist function. He has held previous positions at Danske Capital as Head of North America, and at J.P. Morgan in New York City as Vice President, Strategy & Business Development, and Vice President, Equity Research.